STAT
FDA mulling whether patients should have to pay to join clinical trials
Some [clinical trials] plan to ask participants to pay $7,000 or so to enroll. Another wanted to ask for upward ...
Viewpoint: ‘Natural’ is a feel-good label that can deceive us about the safety of medicine, beauty products and food
People believe that a host of items including foods, medicines, beauty products, cigarettes, lighting, and even causes of injuries are ...
Seeking origins of schizophrenia, autism by putting ‘stress’ on mini-placenta, mini-brains
Biologist Jennifer Erwin of the Lieber Institute for Brain Development, however, has no intention of babying her organoids: the world’s ...
Viewpoint: We need to stop worrying about whether people can cope with bad news from genetic tests
When the Human Genome Project began in 1990, bioethicists feared that giving people the results of genetic tests would do ...
There’s a medical dispute over how long it takes to predict recovery prospects for patients with traumatic brain injuries
The current practice in most ICUs is to help families make a decision about whether to withdraw life support within ...
‘Google’ for biomedical data could improve our understanding of diseases, improve treatments
If we aggregated all the data from countless years of research, might we learn something new about ourselves, the diseases ...
Mayo Clinic versus Natural News: Rating the reliability of health websites
For millions of Americans, including health professionals, the resurgence of measles is a confounding and frightening development. How can a ...
Convulsive seizures could play a key role in Alzheimer’s disease
It’s no surprise to neurologists that some people experience convulsive seizures in the later stages of [Alzheimer’s] disease. … But ...
Frequent errors with popular dementia test prompt review, new training requirements
Dr. Ronny Jackson, then the White House physician, gave Donald Trump a standard test to detect early signs of dementia ...
Heart monitoring by Fitbit, other wearables, may be less accurate for people with dark skin
Nearly all of the largest manufacturers of wearable heart rate trackers rely on technology that could be less reliable for ...
First attempt at using CRISPR to edit genes inside the body targets inherited form of blindness
Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the ...
Genetic sequencing of 50-year-old tissue sample boosts theory that HIV emerged 100 years ago
For more than 50 years, the RNA remained hidden in a lymph node that had been snipped out of a ...
LGBT people may have higher risk for Alzheimer’s, dementia. Are social stressors to blame?
LGBT Americans report increased rates of memory loss and confusion — two early signs of dementia — compared to their ...
Viewpoint: Trump’s proposed drug price cap would threaten gene therapies, cell-based therapies by stifling innovation
President Trump has said he plans to issue an executive order to lower what the United States government would pay ...
‘Cancer vaccine’ boosts survival rates when combined with immunotherapy drugs in small study
The largest study to date of a “cancer vaccine” plus one of the immunotherapy drugs that has revolutionized cancer treatment ...
We may soon have a routine blood test for Alzheimer’s risk
Scientists are closing in on a long-sought goal — a blood test to screen people for possible signs of Alzheimer’s ...
Elon Musk developing brain implant that would control computers, smartphones with our thoughts
His [Elon Musk] startup Neuralink has developed technology meant to be implanted into the brain that’s designed to allow people ...
Spinal cord tumor illustrates long-term risks of controversial stem cell therapies
Stem cell therapies have the potential to treat many conditions, but so far there’s little proof that they do. Even ...
Creating a synthetic version of the Ebola virus to help fight the real thing
Scientists at the Centers from Disease Control and Prevention have created a synthetic version of the Ebola virus circulating in ...
Deadly superbug Candida auris is wreaking havoc in hospitals. Where’s the research money needed to stop it?
In the universe of scary drug-resistant pathogens that can kill, Candida auris is having a moment. The freaky fungus, which ...
How a combination of rare mutations created devastating heart problems for this family
Heritable diseases — say Huntington’s, sickle cell anemia, or cystic fibrosis — are typically thought of as the result of ...
AI promises to improve cancer care through precision medicine. Oncologists are starting to agree.
To get a better handle on the collective “take” on artificial intelligence for cancer care, my colleagues and I at ...
Inside the quest to find a place in modern medicine for magic mushrooms as a treatment for depression, other mental illnesses
Today, with a net worth of roughly $400 million accrued through various enterprises, [German financier Christian] Angermayer is one of ...
‘Uncharted territory’: Doctors struggle with patient demand for unproven CBD supplements
[Jacqueline] French, a neurologist at New York University’s Langone Health, tries to steer her patients away from sprinting to the ...
Viewpoint: We must embrace ‘risk taking’ in the quest to cure Alzheimer’s
For common neurodegenerative diseases like Alzheimer’s, nothing has worked so far to slow the course of the disease in spite ...
Here’s how artificial intelligence could ‘poison’ healthcare
Artificial intelligence is often hailed as a great catalyst of medical innovation, a way to find cures to diseases that ...
Podcast: Talking CRISPR with controversial biohacker Josiah Zayner
Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? ...
5 ways we could pay for expensive life-saving gene therapies
We have arrived at a special moment in health care. Innovative, life-changing gene therapies are here that will cure or ...
